MEDICINAL COMPOSITION FOR PROMOTING GLUCOSE-RESPONSIVE INSULIN SECRETION

摘要

A product in the field of medicines. More specifically speaking, a medicine characterized in that a compound having an effect of inhibiting hedgehog signaling is applied as the active ingredient to diseases for the prevention and treatment of which glucose-responsive insulin secretion should be promoted. By administering the hedgehog signaling inhibitor as described above, insulin secretion by pancreatic Langerhans ß-cells is promoted so that advantageous preventive and therapeutic effects can be exerted on various disease relating to blood sugar control failures such as diabetes.